Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Med-X is Scopus-indexed (Q2, CiteScore 7.5), WoS ESCI. Published by Springer.
Checked against the index lists dated .
ISSN 2097-440XVerify ISSN ↗2731-8710Verify ISSN ↗
Publisher: Springer
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 95 / 342 | 72nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q2, CiteScore 7.5.
Med-X is Q2 in Biomedical Engineering (rank 95 of 342), by CiteScore 2025.
Med-X is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.5, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.127, quartile Q1, with an H-index of 12.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Med-X is published by Springer. Its print ISSN is 2097-440X and its online ISSN is 2731-8710.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Med-X has an h-index of 17 and a 2-year mean of 9 citations per paper (OpenAlex). Its Scopus CiteScore is 7.5, quartile Q2. On 2-year citations it ranks #24 of 322 Scopus journals in Biomedical Engineering.
Med-X published 27 papers in 2025; its busiest recent year was 2024 with 28. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 88 research articles (2023–2026), authors are most often from United States (44.2%), China (39.4%) and South Korea (4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.